Edgewise Therapeutics (EWTX) Earnings Date, Estimates & Call Transcripts $28.40 +1.77 (+6.65%) (As of 10/4/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateNov. 14EstimatedActual EPS (Aug. 8) -$0.34 Beat By $0.02 Consensus EPS (Aug. 8) -$0.36 Conference Call TranscriptConference Call AudioEarnings Press Release Get Edgewise Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for EWTX and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueEWTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.EWTX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto 101 MediaCrypto Crash Ahead? (27 Experts Weigh In)Donald Trump and his team just announced a brand new crypto project... They believe right now could be the perfect buying opportunity… And you have the chance to be a part of it! Claim your free ticket to the event now… Edgewise Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($0.41)($0.30)($0.36)Q2 20242($0.43)($0.31)($0.37)Q3 20242($0.45)($0.35)($0.40)Q4 20242($0.47)($0.39)($0.43)FY 20248($1.76)($1.35)($1.56)Q1 20251($0.41)($0.41)($0.41)Q4 20251($0.55)($0.55)($0.55)EWTX Earnings Date and InformationEdgewise Therapeutics last announced its quarterly earnings results on August 8th, 2024. The reported ($0.34) EPS for the quarter, beating analysts' consensus estimates of ($0.36) by $0.02. Edgewise Therapeutics has generated ($1.55) earnings per share over the last year (($1.55) diluted earnings per share). Earnings for Edgewise Therapeutics are expected to decrease in the coming year, from ($1.47) to ($1.82) per share. Edgewise Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off prior year's report dates.Read More Edgewise Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/14/2024(Estimated)------- 8/8/2024-($0.36)($0.34)+$0.02($0.34)-- 5/9/2024Q1 2024($0.39)($0.33)+$0.06($0.33)-- 2/22/2024Q4 2023($0.44)($0.47)($0.03)($0.47)-- 11/9/2023Q3 2023($0.40)($0.41)($0.01)($0.41)-- 8/10/2023Q2 2023($0.41)($0.34)+$0.07($0.34)-- 5/11/2023Q1 2023($0.37)($0.36)+$0.01($0.36)-- Get the Latest News and Ratings for EWTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Edgewise Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/23/2023Q4 2022($0.36)($0.31)+$0.05($0.31)--11/3/2022Q3 2022($0.36)($0.34)+$0.02($0.34)--8/4/2022Q2 2022($0.34)($0.32)+$0.02($0.32)--5/11/2022Q1 2022($0.29)($0.30)($0.01)($0.30)--2/24/2022Q4 2021($0.28)($0.26)+$0.02($0.26)-- 11/10/2021Q3 2021($0.21)($0.26)($0.05)($0.26)--8/9/2021Q2 2021($0.17)($0.21)($0.04)($0.21)--5/13/2021Q1 2021($0.16)($0.14)+$0.02$4.09-- Edgewise Therapeutics Earnings - Frequently Asked Questions When is Edgewise Therapeutics's earnings date? Edgewise Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off last year's report dates. Learn more on EWTX's earnings history. Did Edgewise Therapeutics beat their earnings estimates last quarter? In the previous quarter, Edgewise Therapeutics (NASDAQ:EWTX) reported ($0.34) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.36) by $0.02. Learn more on analysts' earnings estimate vs. EWTX's actual earnings. How can I listen to Edgewise Therapeutics's earnings conference call? The conference call for Edgewise Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Edgewise Therapeutics's conference call transcript? The conference call transcript for Edgewise Therapeutics's latest earnings report can be read online. Read Transcript How much profit does Edgewise Therapeutics generate each year? Edgewise Therapeutics (NASDAQ:EWTX) has a recorded net income of -$100.16 million. EWTX has generated -$1.55 earnings per share over the last four quarters. What is Edgewise Therapeutics's EPS forecast for next year? Edgewise Therapeutics's earnings are expected to decrease from ($1.47) per share to ($1.82) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Kura Oncology Earnings Results AnaptysBio Earnings Results Arcturus Therapeutics Earnings Results MaxCyte Earnings Results Heron Therapeutics Earnings Results Solid Biosciences Earnings Results Gossamer Bio Earnings Results Legend Biotech Earnings Results Roivant Sciences Earnings Results Ascendis Pharma A/S Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Nike’s Post-Earnings Drop Presents a Buying OpportunityMicron Stock Soars as AI Demand Fuels Big Q4 Earnings BeatGameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season? This page (NASDAQ:EWTX) was last updated on 10/6/2024 by MarketBeat.com Staff From Our PartnersThe panic button has already been pressedIf you missed it, my emergency election broadcast is now available on replay.Porter & Company | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredAI Expert Reveals New PickEveryone’s talking about AI right now, but I’ve been talking about it for years. And now I’ve just released...Brownstone Research | SponsoredNo matter the outcome of the election, it could be a death sentence for your wealth...In today's financial landscape, many investors are feeling disillusioned and disappointed with traditional inv...Allegiance Gold | SponsoredGolden Equation: Volatility = OpportunityWhen the market swings wildly, most investors panic… But it doesn't have to be this way. You see, when t...Prosper Trading Academy | SponsoredJeff Bezos Just Humiliated Elon MuskThe Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next...InvestorPlace | SponsoredWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)The Dow recently shed nearly 1,000 points in a single day… Big tech stocks are getting slaughtered… And ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edgewise Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Edgewise Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
